FGFR3, HRAS, KRAS, NRAS and PIK3CA Mutations in Bladder Cancer and Their Potential as Biomarkers for Surveillance and Therapy.
| Autor: | Kompier, Lucie C.1, Lurkin, Irene1, van der Aa, Madelon N. M.1, van Rhijn, Bas W. G.2, van der Kwast, Theo H.3, Zwarthoff, Ellen C.1 e.zwarthoff@erasmusmc.nl |
|---|---|
| Zdroj: | PLoS ONE. 2010, Vol. 5 Issue 11, p1-13. 13p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|